GlaxoSmithKline Survey Offers New Insights Across Globe to 'Confront COPD'
January 23, 2015 |
January 23, 2015 - While the long-term health outlook for patients with chronic obstructive pulmonary disease (COPD) has improved compared to ten years ago, patients still face significant challenges complying with their medication regimens and, in some countries, accessing preferred treatments, which could result in sub-optimal management, according to the recent survey published in the International Journal of COPD.
The survey entitled “Continuing to Confront COPD International Survey’” was conducted by GlaxoSmithKline and involved 4,343 patients and 1,307 physicians.
“This international survey of patients and physicians, conducted in twelve countries, shows that while we have come a long way in the perception and treatment of COPD over the past ten years, we still have a long way to go,” said Dr. David Mannino, Professor, Division of Pulmonary Critical Care Medicine, University of Kentucky and a member of the COPD Foundation Board of Directors. “For example, 79% of physicians agreed with the statement that the long-term health outlook for patients with COPD has improved over the past decade. Patient access to medications remains problematic in many countries and, surprisingly, 39% of physicians and 46% of patients agreed with the statement “there are no truly effective treatments for COPD,” he added.
;Read the full press release here.